Orthobond Delivers Its First OSTAGUARD™ Coated Implants for Surgery

PRINCETON, N.J.--(BUSINESS WIRE)--Orthobond Corporation, a leader in covalently-bound antibacterial surface technologies with broad applications in the medical device industry, today announced the successful in-house production and commercial delivery of its OSTAGUARD™ coated first in human components. This accomplishment comes only eight months after the FDA granted De Novo clearance for OSTAGUARD, a non-eluting coating designed to actively kill bacteria that contaminate the surface of a medic